APTNOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
ADAPTIN BIO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.27+0.00 (0.00%)
Close on Aug 19, 2026
- Market cap
- $55.48M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Adaptin Bio from other investors
No posts about APTN yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.